Competitive landscape and key differentiators of the commercial novel technologies in cell biology research tool market.
Executive summary
The global single cell technology (SCT) market has emerged since the mid- 2010s. There are 52 companies with more than 60 SCT products commercialized worldwide, and over 30 pre-commerce-stage startups to enter the market. Primarily, the SCT market is young and complex, over 75% of the products were launched within the last 7 years, mostly driven by less than 10 years old startups, and characterized by its wide range of technology mixtures and various types of users across various life science research fields. The general functionalities of the SCT are single cell (SC) isolation/dispensing, SC-sequencing, SC-protein analysis, and novel SC characterization tools. This report is focused on the four main market segments that focus on basic research purposes, which are image-based single-cell isolation, single-cell omics (SC-sequencing & proteomics) and novel cell characterization tools. The market size of those four market segments is ~ $1 billions in 2020, at a CAGR of ~37.6%. The report also features emerging market products in spatial omics analysis, label-free live-cell imaging, microfluidic chip-based flow cytometry. The market share is highly concentrated on major companies (10x genomics, Fluidigm, Berkeley light and BD biosciences), yet this market share can change as the market is expanding with new players and differentiation among players is expected.
Our objectives
A detailed assessment of the three perspectives: financial/business aspects, the market users aspects (biologists), and the new technical aspects (market players).
Key questions answered in this report:
- Who are the single-cell technology (SCT) providers including top 3~5 key players?
- What are their main technical principle and applications?
- How each product is different and what are their competitive advantages and key differentiators?
- What are the current market size, commercial capability, and growth potentials (revenues, install bases, prices)?
- What are the users research objectives, trends, the needs and challenges?
Key features of the report:
COMMERCIAL CAPABILITY ANALYSIS
- Complete list of SC technology providers identification
- Estimated number of installation
- Revenues of each company
- Price of the instruments
- Market size
- Tech providing company size
- Growth potential and trends
CONNECTING TECHNOLOGY AND BIOLOGY
- Overview of the entire single-cell technologies that include basics and applied application.
- Market segmentation by the technology and by the target application
- Global overview of the single-cell biology
- Current workflow of the users
- Current limitation and pain points observed by the customer groups
COMPETITIVE MARKET LANDSCAPE
- The detailed company, product, and technology profiles
- Competitive technical, market strategic analysis for each segmentation group
- Special features on "live-cell imaging technologies" "spatial analysis technologies" and" microfluidic chip-based flow cytometry
COMMERCIAL CAPABILITY ANALYSIS
CONNECTING TECHNOLOGY AND BIOLOGY
COMPETITIVE MARKET LANDSCAPE
Target audience
- Leading Technology Companies
- Investors (Venture capitalists)
- Value-Added Resellers (Third-party knowledge providers, Consulting firms)
Table of Contents
Introduction
- Objectives of the report
- Key features of the report
- Methodology-How the report was written
Executive summary
- 1. Global single cell technology market overview and market player (timeline,location, employee number)
- 2. Market segmentation by technical principle
- 3. Market segmentation by application
- 4. Market size and market share by revenues
- 5. Market trends and growth
- 6. Understanding the customers- overview of SC Biology, their workflow andchallenges
Competitive landscape and key differentiators of the commercialtechnology products by target applications/market segments
1. Intro: physics & chemistry of cellular life in relation to our technicalpossibilities
2. Image-based single-cell picking up isolation technologies
- Presentation of 11 companies, technologies, and commercial capability
- Market share, differentiation between players, competitive analysis
3. Genomics/Transcriptomics/multi-omics technologies
- Presentation of 7 companies and technologies, and commercial capability
- Market share, differentiation between players, competitive analysis
4. Proteomics or protein level analysis technologies
- Presentation of 7 companies and technologies, and commercial capability
- Market share, differentiation between players, competitive analysis
5. Novel cell characterization, cell sorting.
- Presentation of 9 companies and technologies, and commercial capability
- Market share, differentiation between players, competitive analysis
Special features
- 1. Spatial omics analysis (7) technologies
- 2. Label-free live-cell imaging (6) technologies
- 3. Microfluidic chip-based flow cytometry (4) technologies
SCE company presentation
- About Singlecell Enabled and the author
- Related reports and consultation services